CJC-1295 w/o DAC + Ipamorelin is a dual-peptide formulation combining a tetrasubstituted growth hormone-releasing hormone (GHRH) analog and a selective ghrelin receptor agonist that has been studied in preclinical in-vitro and animal models for its synergistic interactions with pituitary somatotroph signaling pathways. It is used as a reference combination in comparative endocrine and pulsatile growth hormone secretagogue research. This formulation is supplied as a lyophilized research material and is studied for its receptor-binding, compound interaction, and cellular regeneration characteristics under controlled experimental conditions. This product is intended for laboratory and research use only. Not for human consumption.